Applied Genetic Technologies C

AGTC

4.11

+0.01

+0.2%

Please Login or Register

Login|Register FREE

Stock Price
Open: 4.15
Prev. Close: 4.10
Low/Hi: 4.10 - 4.20
52-Week: 3.25 - 8.65
Volumes
Equity: 11,113
90-Day Avg: 141,494
Option: 10
90-Day Avg: 47
Volatility
Todays Stock Vol: 32.4
20-Day (HV): 57.6
52-Week (HV): 61.1
30-Day IV: 59.3 +15.0
IV Pct Rank: 61% Moderate
Fundamental
Div. Yield:
Earnings: 8-Feb (Est.)
P/E Ratio:
Market Cap: 74.2 M
Short Int Pct: 0.0%
Pct Held By Inst.: 42.5%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

AGTC Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference Dec 14, 2017
Chardan Gene Therapy Conference Oct 10, 2017
Cell & Gene Meeting on the Mesa Oct 4, 2017 - Oct 6, 2017
FierceBiotech Drug Development Forum Sep 27, 2017
Boston Biotech Conferences Cell & Gene Therapy Sep 25, 2017
Wedbush PacGrow Healthcare Conference Aug 16, 9:45 AM
Association for Research in Vision and Ophthalmology Annual Meeting May 7, 2017 - May 11, 2017
Alliance for Regenerative Medicines 5th Annual Cell & Gene Therapy Investor Day Apr 27, 4:30 PM
29th Annual ROTH Conference Mar 14, 11:30 AM
Gene Therapy World 2017 Jan 20, 2017
BMO Capital Markets Prescriptions for Success Healthcare Conference Dec 14, 3:20 PM
Stifel 2016 Healthcare Conference Nov 15, 2016 New York
i

Sue Washer, President and Chief Executive Officer, will present.

OIS@AAO Oct 13, 2016
i

Sue Washer will participate in the Gene & Stem Cell Therapies Breakfast Breakout Session beginning at 7:30 AM CDT . She will present a brief corporate overview at 11:07 AM CT as part of the conferences Posterior Segment Company Showcase.

BioFlorida Annual Conference Oct 9, 2016 - Oct 11, 2016
i

ue Washer will take part in a discussion titled Florida Areas of Strength: Cell Therapy and Regenerative Medicine at 11:40 AM ET and will be moderating the conferences CEO Panel at 4:55 PM ET on October 10, 2016.

Cell & Gene Meeting on the Mesa Oct 5, 5:45 PM
i

Sue Washer, AGTC President and CEO, will be delivering a company presentation

Wedbush PacGrow Healthcare Conference Aug 16, 2016 New York.
i

Sue Washer, President and Chief Executive Officer, will present.

Ophthalmic Drug Development Summit Jul 26, 2016 - Jul 28, 2016 Washington, D.C.
i

Rabia Ozden, M.D., Vice President of Clinical Research and Development at AGTC, will present on the topic of Progressing Gene Therapies Through The Clinic.

Cantor Fitzgerald Healthcare Conference Jul 13, 11:45 AM
Research Day Jun 21, 11:00 AM New York
i

AGTC management will be joined by two of its scientific collaborators to discuss the range of ophthalmology clinical endpoints, how they are measured, how they define and describe the vision experienced by the patient, and how results in AGTCs clinical development programs could be reported.

Boston CEO Conference May 31, 2016 - Jun 1, 2016 Boston
i

AGTC President & CEO Sue Washer will be participating in a panel discussion

Boston CEO Conference May 31, 2016 - Jun 1, 2016 Boston, Mass
i

AGTC President & CEO Sue Washer will be participating in a panel discussion entitled Genetic Therapies: The promise and the challenge

Piper Jaffray GenomeRx Symposium May 17, 2016 - May 18, 2016 New York, N.Y
i

President & CEO Sue Washer will be participating in a panel discussion entitled Eyes on Gene Therapy For Ophthalmology

Piper Jaffray GenomeRx Symposium May 17, 2016 New York, N.Y
American Society of Gene & Cell Therapy (ASGCT) 19th Annual Meeting May 4, 2016 - May 7, 2016 Washington, D.C
i

Terence R. Flotte, M.D., Celia and Isaac Haidak Professor in Medical Education and dean of the University of Massachusetts School of Medicine, will present new clinical data evaluating the use of recombinant AAV-AAT vector gene delivery to muscle in patients with alpha-1-antitrypsin (AAT) deficiency, an inherited genetic disorder that results in severe loss of lung function caused by complete or partial deficiency of the alpha-1 antitrypsin protein.

Research in Vision and Ophthalmology (ARVO) May 1, 2016 - May 5, 2016 Seattle, Wash
Retinal Cell and Gene Therapy Innovation Summit Apr 28, 2016 - Apr 29, 2016 Seattle, Wash
i

Jeff Chulay, M.D., DTM&H, Vice President and Chief Medical Officer, will lead a session about AGTCs clinical development programs on Thursday, April 28 entitled Development of AAV Gene Therapy Vectors for Achromatopsia and X-Linked Retinitis Pigmentosa.

World Orphan Drug Congress Washington, D.C Apr 20, 2016 - Apr 22, 2016 Washington, D.C.
i

Eric Olson, Senior Director, Corporate Development will give a presentation entitled A novel AAV-based gene therapy platform for the treatment of rare diseases at 4:00PM ET on Thursday, April 21 during which he will discuss AGTCs proprietary gene therapy platform

Alliance for Regenerative Medicine's 4th Annual Cell & Gene Therapy Investor Day Mar 22, 2016 New York, N.Y.
i

Sue Washer, President and CEO, will provide a company presentation

Alliance for Regenerative Medicine's 4th Annual Cell & Gene Therapy Investor Day Mar 22, 2016 New York, N.Y
i

Sue Washer, President and CEO, will provide a company presentation

8th Ocular Diseases Drug Discovery Conference Mar 21, 2016 - Mar 22, 2016 San Diego, Calif
i

Mark Shearman, Ph.D., Chief Scientific Officer, will lead a session titled "Clinical Development of rAAV Gene Therapy for Inherited Retinal Disorders,"

8th Ocular Diseases Drug Discovery Conference Mar 21, 2016 - Mar 22, 2016 San Diego, Calif
i

Sue Washer, President and CEO, will deliver a corporate overview discussing the company's lead programs in ophthalmology, including X-linked retinoschisis (XLRS), achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). To access a live webcast of this presentation, please

ROTH Conference Mar 15, 2016
28th Annual ROTH Conference Mar 13, 2016 - Mar 16, 2016 Dana Point, Calif
i

Sue Washer, President and CEO, will deliver a corporate overview discussing the company's lead programs in ophthalmology, including X-linked retinoschisis (XLRS), achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP

28th Annual ROTH Conference Mar 13, 2016 - Mar 16, 2016 Dana Point, Calif
RBC Capital Markets Global Healthcare Conference Feb 23, 4:35 PM in New York
i

Sue Washer, President and CEO, will present

Phacilitate Cell & Gene Therapy World Jan 25, 2016 - Jan 27, 2016 Washington, D.C
i

Ms. Washer will deliver a keynote address and moderate an investor panel during the opening plenary entitled, Cell & gene therapy State of the Industry on January 25th from 11:25 AM 12:05 PM Ms. Washer will also present on behalf of Southeast BIO (SEBIO) and BioFlorida at the newly established Regional Pavilion at Washington Leaders Forum

Regenerative Medicine's 6th Annual Regenerative Medicine & Advanced Therapies State of the Industry Briefing Jan 11, 2016 San Francisco, Calif
i

AGTC President and CEO Sue Washer will participate in a panel discussion entitled, The 2016 Sector Forecast: Upcoming Clinical Data Events

Piper Jaffray 27th Annual Healthcare Conference Dec 1, 2015
i

participating in a fireside chat as well as a panel discussion on gene therapy for ophthalmology on December 1, 2015.

Stifel 2015 Healthcare Conference Nov 18, 8:00 AM
i

Sue Washer, President and CEO, will present at 8:00 a.m. Eastern Time on November 18, 2015.

Stifel 2015 Healthcare Conference Nov 18, 8:00 AM New York.
i

Sue Washer, President and CEO, will present

Subretinal/Gene Therapy Innovation Summit Nov 13, 2015 Las Vegas
Ophthalmology Innovation Summit Nov 12, 2015 Las Vegas
Stem Cell Meeting on the Mesa Oct 7, 2015 La Jolla, Calif
The Retina Society 48th Annual Scientific Meeting Oct 7, 2015 Paris, France
The Retina Society 48th Annual Scientific Meeting Oct 7, 2015
Leerink Rare Disease Roundtable Sep 30, 2015 New York, N.Y
Discovery on Target Sep 21, 2015 Boston, Mass
Wedbush PacGrow Healthcare Conference Aug 12, 2015 in New York.
Cantor Healthcare Conference Jul 8, 2015
Analyst and Investor Day in New York City Jun 22, 8:30 AM
Boston CEO Conference -- Boston, Mass. (May 26-27, 2015 May 27, 4:00 PM
i

On May 27th at 4:00pm ET, Stephen Potter, Chief Business Officer, will participate in a panel discussion entitled "Genetic Therapies: The Promise and The Challenge." The Boston CEO Conference is a networking forum for industry CEOs and decision makers in the life sciences.

Piper Jaffray GenomeRx Symposium -- New York, N.Y. (May 20-21, 2015) May 20, 1:45 PM
i

On May 20th at 1:45pm ET, Sue Washer, President and CEO, will participate in the Gene Therapy Vector Evolution Panel taking place as part of the Piper Jaffray GenomeRx Symposium.

American Society of Gene & Cell Therapy (ASGCT) 18th Annual Meeting -- New Orleans, La. (May 13-16, 2015) May 13, 2015
i

AGTC will present new preclinical data related to the safety of the company's AAV vector gene therapies for the treatment of achromatopsia and X-linked retinoschisis. Additional new safety data will be presented on the company's proprietary manufacturing process. The new results will be presented in four abstracts: Abstract #350775 -- Safety and Biodistribution Study of rAAV2tYF-CB-hRS1 in RS1-deficient Mice Abstract #350780 -- Safety and Biodistribution Study of rAAV2tYF-CB-hRS1 in Nonhuman Primates Abstract #350277 -- Initial Safety Evaluation of rAAV-hCNGB3 Vectors in Nonhuman Primates Abstract #350887 -- Efficient Clearance of Herpes Simplex Virus Using a GMP-compliant Method for Production of Recombinant Adeno-associated Virus Vectors

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) -- Denver, Colo. (May 3-7, 2015) May 7, 10:30 AM
i

AGTC will present new preclinical data evaluating the efficacy of recombinant AAV expressing hCNGB3 driven by various promoters in CNGB3 knock-out mice. The study (abstract #5477), titled "Rescue of Cone ERG Function by Treatment with AAV-hCNGB3 Vectors in CNGB3 Knockout Mice," will be presented in a poster session from 8:30-10:15am MT on May 7th.

BioFlorida Celebration of Biotechnology -- Alachua, Fla. (May 7, 2015 May 7, 2015
i

AGTC will be a sponsor of the BioFlorida Celebration of Biotechnology, an annual event for the Florida life sciences community hosted by BioFlorida

Wait, Before You Leave...

Want to Know More About AGTC Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon